Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

baxter d.o.o., letališka cesta 29a, ljubljana, slovenija - ciklofosfamid hidrat - prašak za otopinu za injekciju/infuziju - 500 mg - urbroj: jedna bočica sadrži 500 mg ciklofosfamida u obliku ciklofosfamid hidrata

Europska Unija - hrvatski - EMA (European Medicines Agency)

astrazeneca ab - gefitinib - karcinom, ne-malih stanica pluća - antineoplastična sredstva - Иресса indiciran za liječenje odraslih bolesnika s lokalno-uobičajena ili metastatskih немелкоклеточным raka pluća s aktivacijom mutacija epidermalnog faktora rasta-рецепторных тирозинкиназ.

Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan pharmaceuticals limited - gefitinib - karcinom, ne-malih stanica pluća - antineoplastic agents, protein kinase inhibitors - gefitinib mylan u određenom u monoterapiji za liječenje odraslih bolesnika s lokalno-uobičajena ili metastatskih немелкоклеточным raka pluća (НМРЛ) koja aktivira mutacije РЭФР‑tk.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna filmom obložena tableta sadrži 250 mg gefitiniba

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - gefitinib - filmom obložena tableta - 250 mg - urbroj: svaka tableta sadrži 250 mg gefitiniba

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - everolimus - tableta - 5 mg/1 tableta - 1 tableta sadrži: 5 mg everolimusa

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba

Europska Unija - hrvatski - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplazme dojki - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Europska Unija - hrvatski - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.